United States, June 8 -- GE HealthCare announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour ProtegeAI+ (TM) 2.0, an AI-enabled auto-contouring software to assist radiation oncology care teams with treatment planning. This can help clinicians reduce treatment planning time, enabling them to focus on delivering more timely and personalized care for patients.The FDA clearance includes a Predetermined Change Control Plan (PCCP), which establishes a framework for introducing future model updates and enhancements. This will help enable the expansion of models across additional anatomical regions and imaging modalities.According to the World Health Organization, cancer continues to be...